RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Expanding Global Pharmaceutical Harmonization: A Look at ASEAN’s PPWG and The Americas’ PANDRH

Expanding Global Pharmaceutical Harmonization: A Look at ASEAN’s PPWG and The Americas’ PANDRH

Posted 01 March 2010 | By

As the biopharmaceutical industry extends its global reach, various regions of the world are embracing harmonization. Nations and regions other than the EU, Japan and the US-the three that constitute the International Conference on Harmonisation (ICH)-are working with ICH to adopt many of its technical requirements and regulatory processes so they can join their ICH1 colleagues in the race to develop safe and effective therapies.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.